Accurate timing of urine-collection periods in infants and small children

Variations of sex development: The first German interdisciplinary consensus paper.

Journal of pediatric urology·2019

Classifying Variables on the Basis of Disaggregate Correlations.

Multivariate behavioral research·2016

["Jump in at the deep end" : simulator-based learning in acute care].

Der Anaesthesist·2014

[Sexual orientations].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2013

30 years of ergonomics at 3M: a case study.

Work (Reading, Mass.)·2012

Encephalitis related to primary varicella-zoster virus infection in immunocompetent children.

Journal of the neurological sciences·2002

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Models and components of investigation and bereavement care after sudden and unexpected child death: a scoping review.

The Cochrane database of systematic reviews·2026

Retrospective Evaluation of a New Danish National Guideline: Impact on Neonatal Hypoglycemia and Breastfeeding.

Acta paediatrica (Oslo, Norway : 1992)·2026

An RT-qPCR Assay for Rapid Detection of Coxsackievirus A4.

Viruses·2026

Clinical Profile of RSV Breakthrough Infections After Nirsevimab Introduction.

Viruses·2026

Epidemiology and Clinical Spectrum of Human Bocavirus Infection in Children: A Retrospective Single Center Analysis.

Viruses·2026

Trends in Healthcare-Associated Infections and Antimicrobial Use in a Paediatric Hospital from Bucharest, Romania, Across the Pre-Pandemic, Pandemic, and Post-Pandemic Periods (2017-2024).

Microorganisms·2026

Related Experiment Videos

Accurate timing of urine-collection periods in infants and small children

Related Concept Videos

Variations of sex development: The first German interdisciplinary consensus paper.

Classifying Variables on the Basis of Disaggregate Correlations.

["Jump in at the deep end" : simulator-based learning in acute care].

[Sexual orientations].

30 years of ergonomics at 3M: a case study.

Encephalitis related to primary varicella-zoster virus infection in immunocompetent children.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Models and components of investigation and bereavement care after sudden and unexpected child death: a scoping review.

Retrospective Evaluation of a New Danish National Guideline: Impact on Neonatal Hypoglycemia and Breastfeeding.

An RT-qPCR Assay for Rapid Detection of Coxsackievirus A4.

Clinical Profile of RSV Breakthrough Infections After Nirsevimab Introduction.

Epidemiology and Clinical Spectrum of Human Bocavirus Infection in Children: A Retrospective Single Center Analysis.

Trends in Healthcare-Associated Infections and Antimicrobial Use in a Paediatric Hospital from Bucharest, Romania, Across the Pre-Pandemic, Pandemic, and Post-Pandemic Periods (2017-2024).

Related Experiment Videos

Accurate timing of urine-collection periods in infants and small children

Related Concept Videos

Related Articles